Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2025 08:45 ET | Source: AIM ImmunoTech Inc.

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza

OCALA, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Paul Goepfert, MD, of the University of Alabama-Birmingham...
February 26, 2025 07:00 ET | Source: CytoSorbents

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CytoSorbents Announces Fourth Quarter and Full Year 2024 Earnings Release Date for March 6, 2025
February 07, 2025 08:50 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

OCALA, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced its initiation of a plan to advance Ampligen as a vaccine adjuvant...
January 13, 2015 08:30 ET | Source: PositiveID Corporation

PositiveID Corporation Completes Milestone in Development of Its Firefly Dx Prototype

DELRAY BEACH, Fla., Jan. 13, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today...
January 28, 2014 08:30 ET | Source: AIM ImmunoTech Inc.

A Clinical Update on the Search for a Universal Flu Vaccine: Presentation in Washington, DC on January 30, 2014 in Conjunction With the American Society for Microbiology (ASM) Biodefense Conference

PHILADELPHIA, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today that the ASM Biodefense Meeting is scheduled for January 27-29, 2014 at the Washington Marriott...
September 14, 2011 16:30 ET | Source: PositiveID Corporation

PositiveID Corporation Expands Its Biological Detection Capabilities to Address Avian Flu and Other Pandemic Viruses

DELRAY BEACH, Fla., Sept. 14, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical...
July 30, 2008 21:52 ET | Source: Biota Holdings

LANI Phase II Completed -- Phase III Scheduled

MELBOURNE, AUSTRALIA--(Marketwire - July 30, 2008) - Biota Holdings Limited (ASX: BTA) today announced that its second generation, influenza treatment, CS-8958, has successfully completed its initial...
March 19, 2008 13:29 ET | Source: GIDEON

346 Infectious Diseases and 7,316 Outbreaks Included in New Version of GIDEON Online

LOS ANGELES, CA--(Marketwire - March 19, 2008) - GIDEON Informatics http://www.gideononline.com/content.htm today announced a new version of its Web-based solution, with data on 346 infectious...